Announce Date | 06/24/2025 |
EPS Normalized Actual | $1.06 (Beat by $0.3) |
EPS GAAP Actual | $1.06 (Beat by $0.3) |
Revenue Actual | $0.317884B |
Revenue Surprise | Beat by $317.884M |
Announce Date | 08/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.5257 |
EPS GAAP Estimate | $0.5257 |
Revenue Estimate | $0.2689755B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
May 2029 | 4.24 | 15.41 | 4.21293 | 4.26706 | 1 |
May 2028 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 0.08 | 0.08 | 0.317884B | -0.29% | 317.88M |
FQ1 2025 (Feb 2025) | -1.06 | -1.06 | 0.304524B | -4.02% | 304.52M |
FQ4 2024 (Nov 2024) | -0.49 | -0.49 | 0.274046B | -296.62% | 274.05M |
FQ3 2024 (Aug 2024) | 0.49 | 0.49 | 0.257308B | -363.75% | 257.31M |
FQ2 2024 (May 2024) | -0.64 | -0.64 | 0.318801B | -285.46% | 318.8M |
FQ1 2024 (Feb 2024) | 0.45 | 0.45 | 0.316755B | -248.32% | 316.76M |
FQ4 2023 (Nov 2023) | 0.49 | 0.49 | 1.08692B | -8.15% | 1086.92M |
FQ3 2023 (Aug 2023) | 1.97 | 1.97 | 1.19326B | -18.05% | 1193.26M |
FQ4 Announce Date
08/30/2025 (Pre-Market)
Consensus EPS Estimates
0.5257
Consensus Revenue Estimates
0.2689755B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (May 2027) | 1.0323 | -- | 1.0323 | 1.0323 | 2 |
FQ1 2027 (Feb 2027) | 1.14 | -- | 1.14 | 1.14 | 2 |
FQ4 2026 (Nov 2026) | 0.7856 | -- | 0.7856 | 0.7856 | 2 |
FQ3 2026 (Aug 2026) | 0.6741 | -- | 0.6741 | 0.6741 | 2 |
FQ2 2026 (May 2026) | 0.8336 | 90.4 | 0.8112 | 0.85596 | 1 |
FQ1 2026 (Feb 2026) | 0.7019 | 251.02 | 0.66409 | 0.74523 | 1 |
FQ4 2025 (Nov 2025) | 0.73537 | 166.63 | 0.70862 | 0.75131 | 1 |
FQ3 2025 (Aug 2025) | 0.5257 | 6.79 | 0.50176 | 0.5535 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (May 2027) | 0.33B | -- | 0.33B | 0.33B | 3 |
FQ1 2027 (Feb 2027) | 0.33B | -- | 0.33B | 0.33B | 3 |
FQ4 2026 (Nov 2026) | 0.3B | -- | 0.3B | 0.3B | 3 |
FQ3 2026 (Aug 2026) | 0.28B | -- | 0.28B | 0.28B | 3 |
FQ2 2026 (May 2026) | 0.3B | -4.53 | 0.3B | 0.31B | 1 |
FQ1 2026 (Feb 2026) | 0.3B | 0.06 | 0.29B | 0.32B | 2 |
FQ4 2025 (Nov 2025) | 0.28B | 3.01 | 0.27B | 0.29B | 1 |
FQ3 2025 (Aug 2025) | 0.27B | 4.34 | 0.26B | 0.28B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 0.08 | 0.08 | 100% | |
FQ1 2025 (Feb 2025) | -1.06 | -1.06 | 100% | |
FQ4 2024 (Nov 2024) | -0.49 | -0.49 | 100% | |
FQ3 2024 (Aug 2024) | 0.49 | 0.49 | 100% | |
FQ2 2024 (May 2024) | -0.64 | -0.64 | 100% | |
FQ1 2024 (Feb 2024) | 0.45 | 0.45 | 100% | |
FQ4 2023 (Nov 2023) | 0.49 | 0.49 | 100% | |
FQ3 2023 (Aug 2023) | 1.97 | 1.97 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $0.32B | $317.88M | 100% |
FQ1 2025 (Feb 2025) | $0B | $0.3B | $304.52M | 100% |
FQ4 2024 (Nov 2024) | $0B | $0.27B | $274.05M | 100% |
FQ3 2024 (Aug 2024) | $0B | $0.26B | $257.31M | 100% |
FQ2 2024 (May 2024) | $0B | $0.32B | $318.8M | 100% |
FQ1 2024 (Feb 2024) | $0B | $0.32B | $316.76M | 100% |
FQ4 2023 (Nov 2023) | $0B | $1.09B | $1086.92M | 100% |
FQ3 2023 (Aug 2023) | $0B | $1.19B | $1193.26M | 100% |